Prostate News Archive
28-Mar-2007
FDA staff says drug for prostate cancer works (Seattle Post-Intelligencer)
Dendreon Corp.'s Provenge appeared to safely treat prostate cancer in a trial of the first drug designed to stimulate the body's immune system to fight tumors, U.S. regulators said Tuesday. Urine test may improve prostate cancer screening (Reuters via Yahoo! News)
Testing for the prostate cancer gene 3 (PCA3) in urine may improve screening for prostate cancer, new research suggests. Prostate biopsy may be misleading in obese men (Reuters via Yahoo! News)
In overweight or obese men, prostate biopsy may underestimate the aggressiveness of prostate cancer, research suggests. Active Biotech Publishes Data Regarding the TASQ Prostate Cancer Project (RedNova)
Active Biotech (ACTI.ST) publishes a new paper* in the next issue of the scientific journal "The prostate", in collaboration with Dr. John T. Isaacs of The Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Back to Prostate News Archive
